Track topics on Twitter Track topics that are important to you
Glovco (M) Sdn Bhd is a well established, MS ISO9002 accredited glove manufacturer, with production capacity of 50 to 60 million pieces gloves per month. Current turnover is RM38 million per annum. The Glovco Group has a total paid up capital of RM12.80 million.
Incorporated in 1988, production commenced in 1989. The Company progressed over the years with full commitment to quality in all aspects of our operation to the final product. Customers demand for further expansion saw our own factory developed on a 4.7 acres site operational in 1997 with 10 machines.
Continued Research & Development and exploitation of new technology has allowed the redefining of quality standards for our product upwards, and enhanced our competitiveness in the world market. The groundwork for quality was established from the beginning by the introduction of the Good Manufacturing Practice (GMP). In line with the GMP and its philosophy of "Quality without Compromise", a series of stringent testing and inspections are instituted throughout the production process, to ensure total quality control.
PO Box 133
United States of America
Fax: (212) 656-1047
Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...
MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
GLOVCO manufactures new natural rubber latex examination gloves. New reduced protein and polymer coated natural rubber latex examination gloves should reduce concerns about latex allergy and glove pow...
Glovco (M) Sdn Bhd is a well established, MS ISO9002 accredited glove manufacturer, with production capacity of 50 to 60 million pieces gloves per month. Current turnover is RM38 million per annum. Th...
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
We have published hundreds of GLOVCO Limited news stories on BioPortfolio along with dozens of GLOVCO Limited Clinical Trials and PubMed Articles about GLOVCO Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GLOVCO Limited Companies in our database. You can also find out about relevant GLOVCO Limited Drugs and Medications on this site too.